U.S. researchers made the super-aspirin efficacy Strong is about 25 times

U.S. researchers two aspirin derivatives mixed together to make a "super aspirin. The experimental results show that this new type of aspirin can inhibit the growth of more than ten kinds of cancer, and non-destructive mice normal cells. The researchers said the "super aspirin developed into drugs people are still a few years.

Derivatives of a mixture of
City College of New York researchers published this month, "American Chemical Society Drug Chemical Letters papers wrote that this new type of aspirin can inhibit colon cancer, pancreatic cancer, lung cancer, prostate cancer, breast cancer, leukemia and other 11 kinds of malignant cell growth, and not prejudicial to the normal cells.

This "super" aspirin called nitric oxide hydrogen sulfide (NOSH) aspirin, a mixture of previously developed two aspirin derivatives, a derivative of the release of nitric oxide, help protect the gastric mucosa, another release of hydrogen sulfide to enhance the ability of aspirin cancer.

The researchers found that mixing up of two kinds of derivatives more secure than any one alone; on anti-cancer effect in terms of a mixture of aspirin stronger than nitric oxide 1.5 times, 80 times stronger than the hydrogen sulfide aspirin.